| Year |
Citation |
Score |
| 2023 |
Sabri B, Budhathoki C, McFall AM, Mehta SH, Celentano DD, Solomon SS, Srikrishnan AK, Anand S, Vasudevan CK, Lucas GM. Cumulative violence exposures among men who have sex with men living with HIV in India: Psychosocial correlates of HIV care continuum outcomes. Plos One. 18: e0295225. PMID 38039322 DOI: 10.1371/journal.pone.0295225 |
0.497 |
|
| 2023 |
McFall AM, Solomon SS, Lau B, Latkin C, Srikrishnan AK, Anand S, Vasudevan CK, Kumar MS, Lucas GM, H Mehta S. Respondent-driven sampling is more efficient than facility-based strategies at identifying undiagnosed people who inject drugs living with HIV in India. Drug and Alcohol Dependence. 249: 110834. PMID 37352733 DOI: 10.1016/j.drugalcdep.2023.110834 |
0.503 |
|
| 2023 |
Ganapathi L, McFall AM, Greco KF, Srikrishnan AK, Kumar MS, Mayer KH, O'Cleirigh C, Mehta SH, Lucas GM, Solomon SS. Buprenorphine treatment receipt characteristics and retention among people who inject drugs at Integrated Care Centers in India. Drug and Alcohol Dependence. 246: 109839. PMID 37031487 DOI: 10.1016/j.drugalcdep.2023.109839 |
0.418 |
|
| 2022 |
Clipman SJ, Mehta SH, Mohapatra S, Srikrishnan AK, Zook KJC, Duggal P, Saravanan S, Nandagopal P, Kumar MS, Lucas GM, Latkin CA, Solomon SS. Deep learning and social network analysis elucidate drivers of HIV transmission in a high-incidence cohort of people who inject drugs. Science Advances. 8: eabf0158. PMID 36260674 DOI: 10.1126/sciadv.abf0158 |
0.402 |
|
| 2022 |
Clipman SJ, Solomon SS, Srikrishnan AK, McFall AM, Gomathi S, Saravanan S, Anand S, Vasudevan CK, Kumar MS, Celentano DD, Mehta SH, Lucas GM. Antiretroviral Drug Resistance in HIV Sequences From People Who Inject Drugs and Men Who Have Sex With Men Across 21 Cities in India. Open Forum Infectious Diseases. 9: ofac481. PMID 36225747 DOI: 10.1093/ofid/ofac481 |
0.373 |
|
| 2022 |
Prata Menezes NS, Solomon SS, Mcfall AM, Srikrishnan AK, Vasudevan CK, Kumar MS, Celentano DD, Mehta SH, Lucas GM. Changes in HIV care continuum indicators among community-based samples of HIV-infected people who inject drugs and men who have sex with men across 21 cities in India. Aids Care. 1-10. PMID 36120904 DOI: 10.1080/09540121.2022.2119470 |
0.55 |
|
| 2022 |
Muiru AN, Madden E, Scherzer R, Horberg MA, Silverberg MJ, Klein MB, Mayor AM, Gill MJ, Napravnik S, Crane HM, Marconi VC, Koethe JR, Abraham AG, Althoff KN, Lucas GM, et al. Effect of adopting the new race-free 2021 CKD-EPI eGFR creatinine equation on racial differences in kidney disease progression among people with HIV; an observational study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 36069064 DOI: 10.1093/cid/ciac731 |
0.38 |
|
| 2022 |
McFall AM, Menezes NP, Srikrishnan AK, Solomon SS, Anand S, Baishya JJ, Lucas GM, Celentano DD, Mehta SH. Impact of the COVID-19 pandemic on HIV prevention and care services among key populations across 15 cities in India: a longitudinal assessment of clinic-based data. Journal of the International Aids Society. 25: e25960. PMID 35818314 DOI: 10.1002/jia2.25960 |
0.466 |
|
| 2022 |
Patel EU, Solomon SS, Mcfall AM, Prata Menezes N, Tomori C, Srikrishnan AK, Kumar MS, Celentano DD, Lucas GM, Mehta SH. Drug use stigma, antiretroviral therapy use, and HIV viral suppression in a community-based sample of people with HIV who inject drugs. Aids (London, England). PMID 35730390 DOI: 10.1097/QAD.0000000000003297 |
0.514 |
|
| 2022 |
Prabhu S, Mehta SH, McFall AM, Srikrishnan AK, Vasudevan CK, Lucas GM, Celentano DD, Solomon SS. Substance use is associated with condomless anal intercourse among men who have sex with men in India: a partner-level analysis. Bmc Public Health. 22: 722. PMID 35410326 DOI: 10.1186/s12889-022-13192-y |
0.43 |
|
| 2022 |
Korthuis PT, Cook RR, Lum P, Waddell EN, Tookes H, Vergara-Rodriguez P, Kunkel LE, Lucas GM, Rodriguez A, Bielavitz S, Fanucchi L, Hoffman K, Bachrach K, Payne EH, Collins JA, et al. HIV Clinic-Based Extended Release Naltrexone versus Treatment as Usual for People with HIV and Opioid Use Disorder: A Non-Blinded, Randomised Non-inferiority Trial. Addiction (Abingdon, England). PMID 35129242 DOI: 10.1111/add.15836 |
0.38 |
|
| 2021 |
Sabri B, Greene MC, Du S, Solomon SS, Srikrishnan AK, Mehta SH, Lucas GM. Exploring multilevel determinants of co-occurring violence, HIV, mental health and substance use problems. Journal of Ethnic & Cultural Diversity in Social Work. 32: 210-222. PMID 37705883 DOI: 10.1080/15313204.2021.1964119 |
0.349 |
|
| 2021 |
Ganapathi L, Srikrishnan AK, Martinez C, Lucas GM, Mehta SH, Verma V, McFall AM, Mayer KH, Hassan A, Rajan S, O'Cleirigh C, Harris SK, Solomon SS. Young and invisible: a qualitative study of service engagement by people who inject drugs in India. Bmj Open. 11: e047350. PMID 34548348 DOI: 10.1136/bmjopen-2020-047350 |
0.394 |
|
| 2021 |
Prabhu S, Mehta SH, McFall AM, Srikrishnan AK, Vasudevan CK, Lucas GM, Celentano DD, Solomon SS. Role of geospatial mapping in the planning of HIV programs: A case study from Southern India. Medicine. 100: e27092. PMID 34449513 DOI: 10.1097/MD.0000000000027092 |
0.491 |
|
| 2021 |
Clipman SJ, Mehta SH, Srikrishnan AK, Zook KJ, Duggal P, Mohapatra S, Shanmugam S, Nandagopal P, Kumar MS, Ogburn E, Lucas GM, Latkin CA, Solomon SS. Role of direct and indirect social and spatial ties in the diffusion of HIV and HCV among people who inject drugs: A cross-sectional community-based network analysis in New Delhi, India. Elife. 10. PMID 34342266 DOI: 10.7554/eLife.69174 |
0.374 |
|
| 2021 |
Patel EU, Solomon SS, Lucas GM, McFall AM, Srikrishnan AK, Kumar MS, Iqbal SH, Saravanan S, Paneerselvam N, Balakrishnan P, Laeyendecker O, Celentano DD, Mehta SH. Temporal change in population-level prevalence of detectable HIV viraemia and its association with HIV incidence in key populations in India: a serial cross-sectional study. The Lancet. Hiv. PMID 34331860 DOI: 10.1016/S2352-3018(21)00098-9 |
0.468 |
|
| 2021 |
Rosecrans A, Harris R, Saxton RE, Cotterell M, Zoltick M, Willman C, Blackwell I, Bell J, Hayes D, Weir B, Sherman S, Lucas GM, Greenbaum A, Page KR. Mobile low-threshold buprenorphine integrated with infectious disease services. Journal of Substance Abuse Treatment. 108553. PMID 34238629 DOI: 10.1016/j.jsat.2021.108553 |
0.345 |
|
| 2021 |
Rosecrans A, Harris R, Saxton RE, Cotterell M, Zoltick M, Willman C, Blackwell I, Bell J, Hayes D, Weir B, Sherman S, Lucas GM, Greenbaum A, Page KR. Mobile low-threshold buprenorphine integrated with infectious disease services. Journal of Substance Abuse Treatment. 108553. PMID 34238629 DOI: 10.1016/j.jsat.2021.108553 |
0.345 |
|
| 2021 |
Atta M, Zook K, Brown T, Vaidya D, Tao X, Maier P, Schwartz G, Lucas G. Racial Adjustment Adversely Affects Glomerular Filtration Estimates in African Americans Living with HIV. Journal of the American Society of Nephrology : Jasn. PMID 34140402 DOI: 10.1681/ASN.2021030311 |
0.47 |
|
| 2021 |
Allen ST, White RH, O'Rourke A, Schneider KE, Weir BW, Lucas GM, Kilkenny ME, Sherman SG. Syringe Coverage Among People Who Inject Drugs in West Virginia, USA. Aids and Behavior. PMID 33886011 DOI: 10.1007/s10461-021-03247-3 |
0.317 |
|
| 2021 |
Belludi A, McFall AM, Solomon SS, Celentano DD, Mehta SH, Srikrishnan AK, Kumar MS, Solomon S, Lucas GM. Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional survey. Plos One. 16: e0247352. PMID 33630909 DOI: 10.1371/journal.pone.0247352 |
0.409 |
|
| 2020 |
Lucas GM, Atta MG, Zook K, Vaidya D, Tao X, Maier P, Schwartz GJ. Cross-Sectional and Longitudinal Performance of Creatinine- and Cystatin C-Based Estimating Equations Relative to Exogenously Measured Glomerular Filtration Rate in HIV-Positive and HIV-Negative Persons. Journal of Acquired Immune Deficiency Syndromes (1999). 85: e58-e66. PMID 33136753 DOI: 10.1097/QAI.0000000000002471 |
0.417 |
|
| 2020 |
Wagman JA, Wynn A, Matsuzaki M, Gnatienko N, Metsch LR, Del Rio C, Feaster DJ, Nance RM, Whitney BM, Delaney JAC, Kahana SY, Crane HM, Chandler RK, Elliott JC, Altice F, ... Lucas GM, et al. Hazardous alcohol use, antiretroviral therapy receipt and viral suppression in people living with HIV who inject drugs in the U.S., India, Russia and Vietnam. Aids (London, England). PMID 33048870 DOI: 10.1097/QAD.0000000000002716 |
0.424 |
|
| 2020 |
Tariq A, Kim H, Abbas H, Lucas GM, Atta MG. Pharmacotherapeutic options for kidney disease in HIV positive patients. Expert Opinion On Pharmacotherapy. 1-14. PMID 32955946 DOI: 10.1080/14656566.2020.1817383 |
0.603 |
|
| 2020 |
Lucas GM, Atta MG, Zook K, Vaidya D, Tao X, Maier P, Schwartz GJ. Cross-sectional and longitudinal performance of creatinine- and cystatin C-based estimating equations relative to exogenously measured glomerular filtration rate in HIV-positive and HIV-negative persons. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 32826565 DOI: 10.1097/Qai.0000000000002471 |
0.506 |
|
| 2020 |
Dangerfield DT, Cooper J, Heidari O, Allen S, Winder TJA, Lucas GM. Nursing and Health Care Preferences Among Opioid and Stimulant Using Black Sexual Minority Men: An Exploratory Study. The Journal of the Association of Nurses in Aids Care : Janac. PMID 32809988 DOI: 10.1097/Jnc.0000000000000201 |
0.423 |
|
| 2020 |
Dangerfield Ii DT, Heidari O, Cooper J, Allen S, Lucas GM. Motivations for opioid and stimulant use among drug using black sexual minority men: A life course perspective. Drug and Alcohol Dependence. 215: 108224. PMID 32777690 DOI: 10.1016/J.Drugalcdep.2020.108224 |
0.469 |
|
| 2020 |
Jacobs P, Feaster DJ, Pan Y, Gooden L, Daar ES, Lucas G, Jain MK, Marsh E, Armstrong WS, Rodriguez A, Del Rio C, Metsch LR. Initiation of Antiretroviral Therapy in the Hospital is Associated with Linkage to HIV Care for Persons Living with HIV and Substance Use. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32569355 DOI: 10.1093/Cid/Ciaa838 |
0.566 |
|
| 2020 |
Rodgers MA, Gomathi S, Vallari A, Saravanan S, Lucas GM, Mehta S, Solomon SS, Cloherty GA. Diverse HCV Strains And HIV URFS Identified Amongst People Who Inject Drugs In India. Scientific Reports. 10: 7214. PMID 32350342 DOI: 10.1038/S41598-020-64309-5 |
0.465 |
|
| 2019 |
Sabri B, Greene C, Lucas GM. A systematic review of comprehensive interventions for substance abuse: Focus on victimization. Aggression and Violent Behavior. 48: 46-59. PMID 33312052 DOI: 10.1016/J.Avb.2019.08.006 |
0.379 |
|
| 2019 |
Allen ST, O'Rourke A, White RH, Smith KC, Weir B, Lucas GM, Sherman SG, Grieb SM. Barriers and Facilitators to PrEP Use Among People Who Inject Drugs in Rural Appalachia: A Qualitative Study. Aids and Behavior. PMID 31853771 DOI: 10.1007/S10461-019-02767-3 |
0.404 |
|
| 2019 |
Suhas Solomon S, Quinn TC, Solomon S, McFall AM, Srikrishnan AK, Verma V, Kumar MS, Laeyendecker O, Celentano DD, Iqbal SH, Anand S, Vasudevan CK, Saravanan S, Thomas DL, Singh Sachdeva K, ... Lucas GM, et al. Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who inject drugs: A cluster-randomized trial. Journal of Hepatology. PMID 31604081 DOI: 10.1016/J.Jhep.2019.09.022 |
0.449 |
|
| 2019 |
McGinnis KA, Fiellin DA, Skanderson M, Hser YI, Lucas GM, Justice AC, Tate JP. Opioid use trajectory groups and changes in a physical health biomarker among HIV-positive and uninfected patients receiving opioid agonist treatment. Drug and Alcohol Dependence. 204: 107511. PMID 31546119 DOI: 10.1016/J.Drugalcdep.2019.06.014 |
0.472 |
|
| 2019 |
Ganapathi L, McFall AM, Srikrishnan AK, Kumar MS, Anand S, Lucas GM, Mehta SH, Harris SK, Solomon SS. Young people who inject drugs in India have high HIV incidence and behavioural risk: a cross-sectional study. Journal of the International Aids Society. 22: e25287. PMID 31116005 DOI: 10.1002/Jia2.25287 |
0.584 |
|
| 2019 |
Solomon SS, Solomon S, McFall AM, Srikrishnan AK, Anand S, Verma V, Vasudevan CK, Balakrishnan P, Ogburn EL, Moulton LH, Kumar MS, Sachdeva KS, Laeyendecker O, Celentano DD, Lucas GM, et al. Integrated HIV testing, prevention, and treatment intervention for key populations in India: a cluster-randomised trial. The Lancet. Hiv. PMID 30952565 DOI: 10.1016/S2352-3018(19)30034-7 |
0.576 |
|
| 2019 |
Prabhu S, McFall AM, Mehta SH, Srikrishnan AK, Suresh Kumar M, Anand S, Shanmugam S, Celentano DD, Lucas GM, Solomon SS. Psychosocial barriers to viral suppression in a community-based sample of HIV-positive men who have sex with men and people who inject drugs in India. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30840989 DOI: 10.1093/Cid/Ciz175 |
0.425 |
|
| 2019 |
Althoff KN, Gebo KA, Moore RD, Boyd CM, Justice AC, Wong C, Lucas GM, Klein MB, Kitahata MM, Crane H, Silverberg MJ, Gill MJ, Mathews WC, Dubrow R, Horberg MA, et al. Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies. The Lancet. Hiv. PMID 30683625 DOI: 10.1016/S2352-3018(18)30295-9 |
0.482 |
|
| 2018 |
McMahon BA, Hanouneh M, Chedid A, Fine DM, Chen TK, Foy M, Lucas GM, Estrella MM, Atta MG. Association of HIV Suppression with Kidney Disease Progression among HIV-Positive African Americans with Biopsy-Proven Classic FSGS. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 30204721 DOI: 10.1097/Qai.0000000000001860 |
0.591 |
|
| 2018 |
Philbin MM, Feaster DJ, Gooden L, Duan R, Das M, Jacobs P, Lucas GM, Batey DS, Nijhawan A, Jacobson JM, Mandler R, Daar E, McMahon DK, Armstrong WS, Del Rio C, et al. The North-South divide: substance use risk, care engagement, and viral suppression among hospitalized HIV-infected patients in 11 U.S. cities. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29920584 DOI: 10.1016/J.Drugalcdep.2015.07.479 |
0.569 |
|
| 2018 |
Atta MG, De Seigneux S, Lucas GM. Clinical Pharmacology in HIV Therapy. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 29844056 DOI: 10.2215/Cjn.02240218 |
0.551 |
|
| 2018 |
Smith MK, Solomon SS, Cummings DAT, Srikrishnan AK, Kumar MS, Vasudevan CK, McFall AM, Lucas GM, Celentano DD, Mehta SH. Overlap between harm reduction and HIV service utilisation among PWID in India: Implications for HIV combination prevention. The International Journal On Drug Policy. 57: 111-118. PMID 29730586 DOI: 10.1016/J.Drugpo.2018.02.007 |
0.597 |
|
| 2018 |
Elliott JC, Brincks AM, Feaster DJ, Hasin DS, Del Rio C, Lucas GM, Rodriguez AE, Nijhawan AE, Metsch LR. Psychosocial Factors Associated with Problem Drinking Among Substance Users with Poorly Controlled HIV Infection. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 29596589 DOI: 10.1093/Alcalc/Agy021 |
0.525 |
|
| 2017 |
Solomon SS, McFall AM, Lucas GM, Srikrishnan AK, Kumar MS, Anand S, Quinn TC, Celentano DD, Mehta SH. Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis. Plos Medicine. 14: e1002460. PMID 29182638 DOI: 10.1371/Journal.Pmed.1002460 |
0.517 |
|
| 2017 |
Koubar SH, Estrella MM, Warrier R, Moore RD, Lucas GM, Atta MG, Fine DM. Rhabdomyolysis in an HIV cohort: epidemiology, causes and outcomes. Bmc Nephrology. 18: 242. PMID 28716131 DOI: 10.1186/S12882-017-0656-9 |
0.591 |
|
| 2017 |
Achhra AC, Mocroft A, Ross M, Ryom-Nielson L, Avihingsanon A, Bakowska E, Belloso W, Clarke A, Furrer H, Lucas GM, Ristola M, Rassool M, Ross J, Somboonwit C, Sharma S, et al. Impact of early versus deferred antiretroviral therapy on estimated glomerular filtration rate in HIV-positive individuals in the START trial. International Journal of Antimicrobial Agents. PMID 28668686 DOI: 10.1016/J.Ijantimicag.2017.04.021 |
0.568 |
|
| 2017 |
Muzaale AD, Althoff KN, Sperati CJ, Abraham AG, Kucirka LM, Massie AB, Kitahata MM, Horberg MA, Justice AC, Fischer MJ, Silverberg MJ, Butt AA, Boswell SL, Rachlis AR, Mayor AM, ... ... Lucas GM, et al. Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney Donors. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. PMID 28497525 DOI: 10.1111/Ajt.14235 |
0.6 |
|
| 2017 |
Cepeda JA, Solomon SS, Srikrishnan AK, McFall AM, Kumar MS, Vasudevan CK, Anand S, Celentano DD, Lucas GM, Mehta SH. Injection drug network characteristics are important markers of HIV risk behavior and lack of viral suppression. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 28328550 DOI: 10.1097/Qai.0000000000001372 |
0.544 |
|
| 2017 |
Mcfall AM, Solomon SS, Lucas GM, Celentano DD, Srikrishnan AK, Kumar MS, Mehta SH. Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: A respondent-driven sampling study. Addiction (Abingdon, England). PMID 28317210 DOI: 10.1111/Add.13821 |
0.527 |
|
| 2017 |
Schnell KM, Atta MG, Fine DM, Zook K, Mcfall AM, Estrella MM, Schwartz GJ, Lucas GM. Longitudinal assessment of proximal tubular dysfunction in HIV seropositive and seronegative persons: correlates and implications. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 28151777 DOI: 10.1097/Qai.0000000000001302 |
0.568 |
|
| 2017 |
Sabri B, McFall AM, Solomon SS, Srikrishnan AK, Vasudevan CK, Anand S, Celentano DD, Mehta SH, Kumar S, Lucas GM. Gender Differences in Factors Related to HIV Risk Behaviors among People Who Inject Drugs in North-East India. Plos One. 12: e0169482. PMID 28099458 DOI: 10.1371/Journal.Pone.0169482 |
0.479 |
|
| 2016 |
Solomon SS, Lucas GM, Celentano DD, McFall AM, Ogburn E, Moulton LH, Srikrishnan AK, Kumar MS, Anand S, Solomon S, Mehta SH. Design of the Indian NCA study (Indian national collaboration on AIDS): a cluster randomized trial to evaluate the effectiveness of integrated care centers to improve HIV outcomes among men who have sex with men and persons who inject drugs in India. Bmc Health Services Research. 16: 652. PMID 27842543 DOI: 10.1186/S12913-016-1905-5 |
0.511 |
|
| 2016 |
Lucas GM, Atta MG, Fine DM, McFall AM, Estrella MM, Zook K, Stein JH. HIV, Cocaine Use, and Hepatitis C Virus: A Triad of Nontraditional Risk Factors for Subclinical Cardiovascular Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 27609369 DOI: 10.1161/Atvbaha.116.307985 |
0.445 |
|
| 2016 |
Metsch LR, Feaster DJ, Gooden L, Matheson T, Stitzer M, Das M, Jain MK, Rodriguez AE, Armstrong WS, Lucas GM, Nijhawan AE, Drainoni ML, Herrera P, Vergara-Rodriguez P, Jacobson JM, et al. Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial. Jama. 316: 156-170. PMID 27404184 DOI: 10.1001/Jama.2016.8914 |
0.585 |
|
| 2016 |
Atta MG, Estrella MM, Fine DM, Zook K, Monroy Trujillo JM, Stein JH, Lucas GM. Correlates and Longitudinal Renal and Cardiovascular Implications of FGF23 Levels in HIV-Positive Individuals. Plos One. 11: e0155312. PMID 27176000 DOI: 10.1371/Journal.Pone.0155312 |
0.576 |
|
| 2016 |
McFall AM, Mehta SH, Srikrishnan AK, Lucas GM, Vasudevan CK, Celentano DD, Kumar MS, Solomon S, Solomon SS. Getting to 90: linkage to HIV care among men who have sex with men and people who inject drugs in India. Aids Care. 1-10. PMID 27054274 DOI: 10.1080/09540121.2016.1168915 |
0.604 |
|
| 2016 |
Solomon SS, Mehta SH, McFall AM, Srikrishnan AK, Saravanan S, Laeyendecker O, Balakrishnan P, Celentano DD, Solomon S, Lucas GM. Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative study. The Lancet. Hiv. 3: e183-90. PMID 27036994 DOI: 10.1016/S2352-3018(16)00019-9 |
0.548 |
|
| 2016 |
Solomon SS, Mehta SH, McFall AM, Srikrishnan AK, Saravanan S, Laeyendecker O, Balakrishnan P, Celentano DD, Solomon S, Lucas GM. Community viral load, antiretroviral therapy coverage, and HIV incidence in India: A cross-sectional, comparative study The Lancet Hiv. DOI: 10.1016/S2352-3018(16)00019-9 |
0.379 |
|
| 2015 |
Atta MG, Estrella MM, Skorecki KL, Kopp JB, Winkler CA, Wasser WG, Shemer R, Racusen LC, Kuperman M, Foy MC, Lucas GM, Fine DM. Association of APOL1 Genotype with Renal Histology among Black HIV-Positive Patients Undergoing Kidney Biopsy. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 26668025 DOI: 10.2215/Cjn.07490715 |
0.548 |
|
| 2015 |
Lucas GM, Atta MG, Zook K, McFall AM, Mehta SH, Fine DM, Stein JH, Schwartz GJ. Factors associated with iohexol-based glomerular filtration rate slope over 36 months in HIV-negative and HIV-positive individuals. Aids (London, England). PMID 26558732 DOI: 10.1097/QAD.0000000000000949 |
0.507 |
|
| 2015 |
Waheed S, Attia D, Estrella MM, Zafar Y, Atta MG, Lucas GM, Fine DM. Proximal tubular dysfunction and kidney injury associated with tenofovir in HIV patients: a case series. Clinical Kidney Journal. 8: 420-5. PMID 26251709 DOI: 10.1093/Ckj/Sfv041 |
0.433 |
|
| 2015 |
Mehta SH, Lucas GM, Solomon S, Srikrishnan AK, McFall AM, Dhingra N, Nandagopal P, Kumar MS, Celentano DD, Solomon SS. HIV Care Continuum Among Men Who Have Sex With Men and Persons Who Inject Drugs in India: Barriers to Successful Engagement. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 26251048 DOI: 10.1093/Cid/Civ669 |
0.513 |
|
| 2015 |
Waheed S, Sakr A, Chheda ND, Lucas GM, Estrella M, Fine DM, Atta MG. Outcomes of Renal Transplantation in HIV-1 Associated Nephropathy. Plos One. 10: e0129702. PMID 26061701 DOI: 10.1371/Journal.Pone.0129702 |
0.492 |
|
| 2015 |
Solomon SS, Mehta SH, Srikrishnan AK, Vasudevan CK, Mcfall AM, Balakrishnan P, Anand S, Nandagopal P, Ogburn EL, Laeyendecker O, Lucas GM, Solomon S, Celentano DD. High HIV prevalence and incidence among MSM across 12 cities in India. Aids (London, England). 29: 723-31. PMID 25849835 DOI: 10.1097/Qad.0000000000000602 |
0.58 |
|
| 2015 |
Kitahata MM, Drozd DR, Crane HM, Van Rompaey SE, Althoff KN, Gange SJ, Klein MB, Lucas GM, Abraham AG, Lo Re V, McReynolds J, Lober WB, Mendes A, Modur SP, Jing Y, et al. Ascertainment and verification of end-stage renal disease and end-stage liver disease in the north american AIDS cohort collaboration on research and design. Aids Research and Treatment. 2015: 923194. PMID 25789171 DOI: 10.1155/2015/923194 |
0.464 |
|
| 2015 |
Lucas GM, Solomon SS, Srikrishnan AK, Agrawal A, Iqbal S, Laeyendecker O, McFall AM, Kumar MS, Ogburn EL, Celentano DD, Solomon S, Mehta SH. High HIV burden among people who inject drugs in 15 Indian cities. Aids (London, England). 29: 619-28. PMID 25715105 DOI: 10.1097/Qad.0000000000000592 |
0.526 |
|
| 2015 |
Metzger DS, Donnell D, Celentano DD, Jackson JB, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM, Chawarski M, Ruan Y, Richardson P, Shin K, Chen RY, et al. Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058. Journal of Acquired Immune Deficiency Syndromes (1999). 68: 554-61. PMID 25564105 DOI: 10.1097/Qai.0000000000000510 |
0.461 |
|
| 2015 |
Solomon SS, Mehta SH, Srikrishnan AK, Solomon S, McFall AM, Laeyendecker O, Celentano DD, Iqbal SH, Anand S, Vasudevan CK, Saravanan S, Lucas GM, Kumar MS, Sulkowski MS, Quinn TC. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study. The Lancet. Infectious Diseases. 15: 36-45. PMID 25486851 DOI: 10.1016/S1473-3099(14)71045-X |
0.36 |
|
| 2015 |
Abraham AG, Althoff KN, Jing Y, Estrella MM, Kitahata MM, Wester CW, Bosch RJ, Crane H, Eron J, Gill MJ, Horberg MA, Justice AC, Klein M, Mayor AM, Moore RD, ... ... Lucas GM, et al. End-stage renal disease among HIV-infected adults in North America. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 60: 941-9. PMID 25409471 DOI: 10.1093/Cid/Ciu919 |
0.582 |
|
| 2015 |
Waheed S, Sakr A, Chheda ND, Lucas GM, Estrella M, Fine DM, Atta MG. Outcomes of renal transplantation in HIV-1 associated nephropathy Plos One. 10. DOI: 10.1371/journal.pone.0129702 |
0.376 |
|
| 2015 |
Philbin M, Feaster D, Gooden L, Pan Y, Das M, Pati R, Lucas G, Coley H, Nijhawan A, Jacobson J, Mandler R, Daar E, McMahon D, delRio C, Metsch L. The north-south divide: Substance use risk, care engagement, and viral suppression among hospitalized HIV-infected patients in 11 U.S. cities Drug and Alcohol Dependence. 156: e176-e177. DOI: 10.1016/j.drugalcdep.2015.07.479 |
0.42 |
|
| 2014 |
Murakami CA, Attia D, Carter-Monroe N, Lucas GM, Estrella MM, Fine DM, Atta MG. The clinical characteristics and pathological patterns of postinfectious glomerulonephritis in HIV-infected patients Plos One. 9. PMID 25272150 DOI: 10.1371/Journal.Pone.0108398 |
0.509 |
|
| 2014 |
Lucas GM, Ross MJ, Stock PG, Shlipak MG, Wyatt CM, Gupta SK, Atta MG, Wools-Kaloustian KK, Pham PA, Bruggeman LA, Lennox JL, Ray PE, Kalayjian RC. Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 59: e96-138. PMID 25234519 DOI: 10.1093/Cid/Ciu617 |
0.494 |
|
| 2014 |
Lucas GM, Young A, Donnell D, Richardson P, Aramrattana A, Shao Y, Ruan Y, Liu W, Fu L, Ma J, Celentano DD, Metzger D, Jackson JB, Burns D. Hepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine/naloxone in HIV-negative injection opioid users in China and Thailand. Drug and Alcohol Dependence. 142: 139-45. PMID 24999060 DOI: 10.1016/J.Drugalcdep.2014.06.013 |
0.392 |
|
| 2014 |
Foy M, Sperati CJ, Lucas GM, Estrella MM. Drug interactions and antiretroviral drug monitoring. Current Hiv/Aids Reports. 11: 212-22. PMID 24950731 DOI: 10.1007/S11904-014-0212-1 |
0.497 |
|
| 2014 |
Boyd CM, Lucas GM. Patient-centered care for people living with multimorbidity. Current Opinion in Hiv and Aids. 9: 419-27. PMID 24871089 DOI: 10.1097/Coh.0000000000000073 |
0.325 |
|
| 2014 |
Solomon SS, Srikrishnan AK, Vasudevan CK, Anand S, Kumar MS, Balakrishnan P, Mehta SH, Solomon S, Lucas GM. Voucher incentives improve linkage to and retention in care among HIV-infected drug users in Chennai, India. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 59: 589-95. PMID 24803381 DOI: 10.1093/Cid/Ciu324 |
0.568 |
|
| 2014 |
Lambert AA, Drummond MB, Mehta SH, Brown TT, Lucas GM, Kirk GD, Estrella MM. Risk factors for vitamin D deficiency among HIV-infected and uninfected injection drug users. Plos One. 9: e95802. PMID 24756000 DOI: 10.1371/Journal.Pone.0095802 |
0.427 |
|
| 2014 |
Lucas GM, Cozzi-Lepri A, Wyatt CM, Post FA, Bormann AM, Crum-Cianflone NF, Ross MJ. Glomerular filtration rate estimated using creatinine, cystatin C or both markers and the risk of clinical events in HIV-infected individuals. Hiv Medicine. 15: 116-23. PMID 24024499 DOI: 10.1111/hiv.12087 |
0.428 |
|
| 2014 |
Lucas GM, Ross MJ, Stock PG, Shlipak MG, Wyatt CM, Gupta SK, Atta MG, Wools-Kaloustian KK, Pham PA, Bruggeman LA, Lennox JL, Ray PE, Kalayjian RC. Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV medicine association of the infectious diseases society of America Clinical Infectious Diseases. 59: 1203-1207. DOI: 10.1093/cid/ciu730 |
0.482 |
|
| 2014 |
Solomon S, Mehta S, Srikrishnan A, Lucas G, McFall A, Laeyendecker O, Kumar M, Iqbal S, Solomon S, Quinn T. P1279 HIGH BURDEN OF HCV AND HCV/HIV COINFECTION AMONG INJECTION DRUG USERS IN INDIA: NEED FOR INTEGRATION OF HIV AND HCV SERVICES Journal of Hepatology. 60: S516. DOI: 10.1016/S0168-8278(14)61438-0 |
0.445 |
|
| 2013 |
Bhasin B, Lau B, Atta MG, Fine DM, Estrella MM, Schwartz GJ, Lucas GM. HIV viremia and T-cell activation differentially affect the performance of glomerular filtration rate equations based on creatinine and cystatin C. Plos One. 8: e82028. PMID 24376511 DOI: 10.1371/Journal.Pone.0082028 |
0.491 |
|
| 2013 |
Lucas GM, Jing Y, Sulkowski M, Abraham AG, Estrella MM, Atta MG, Fine DM, Klein MB, Silverberg MJ, Gill MJ, Moore RD, Gebo KA, Sterling TR, Butt AA. Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals. The Journal of Infectious Diseases. 208: 1240-9. PMID 23904290 DOI: 10.1093/Infdis/Jit373 |
0.416 |
|
| 2013 |
Lucas GM, Mullen BA, Galai N, Moore RD, Cook K, McCaul ME, Glass S, Oursler KK, Rand C. Directly administered antiretroviral therapy for HIV-infected individuals in opioid treatment programs: results from a randomized clinical trial. Plos One. 8: e68286. PMID 23874575 DOI: 10.1371/Journal.Pone.0068286 |
0.563 |
|
| 2013 |
Solomon SS, Lucas GM, Celentano DD, Sifakis F, Mehta SH. Beyond surveillance: a role for respondent-driven sampling in implementation science. American Journal of Epidemiology. 178: 260-7. PMID 23801014 DOI: 10.1093/Aje/Kws432 |
0.418 |
|
| 2013 |
Foy MC, Estrella MM, Lucas GM, Tahir F, Fine DM, Moore RD, Atta MG. Comparison of risk factors and outcomes in HIV immune complex kidney disease and HIV-associated nephropathy. Clinical Journal of the American Society of Nephrology : Cjasn. 8: 1524-32. PMID 23685946 DOI: 10.2215/Cjn.10991012 |
0.597 |
|
| 2013 |
Solomon SS, Lucas GM, Kumarasamy N, Yepthomi T, Balakrishnan P, Ganesh AK, Anand S, Moore RD, Solomon S, Mehta SH. Impact of generic antiretroviral therapy (ART) and free ART programs on time to initiation of ART at a tertiary HIV care center in Chennai, India. Aids Care. 25: 931-6. PMID 23216257 DOI: 10.1080/09540121.2012.748160 |
0.481 |
|
| 2012 |
Atta MG, Estrella MM, Kuperman M, Foy MC, Fine DM, Racusen LC, Lucas GM, Nelson GW, Warner AC, Winkler CA, Kopp JB. HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics. Kidney International. 82: 338-43. PMID 22495294 DOI: 10.1038/Ki.2012.111 |
0.373 |
|
| 2012 |
Estrella MM, Kirk GD, Mehta SH, Brown TT, Fine DM, Atta MG, Lucas GM. Vitamin D deficiency and persistent proteinuria among HIV-infected and uninfected injection drug users. Aids (London, England). 26: 295-302. PMID 22156964 DOI: 10.1097/Qad.0B013E32834F33A2 |
0.47 |
|
| 2012 |
Lucas GM, Beauchamp G, Aramrattana A, Shao Y, Liu W, Fu L, Jackson JB, Celentano DD, Richardson P, Metzger D. Short-term safety of buprenorphine/naloxone in HIV-seronegative opioid-dependent Chinese and Thai drug injectors enrolled in HIV Prevention Trials Network 058. The International Journal On Drug Policy. 23: 162-5. PMID 21852093 DOI: 10.1016/J.Drugpo.2011.06.005 |
0.466 |
|
| 2011 |
George E, Nadkarni GN, Estrella MM, Lucas GM, Sperati CJ, Atta MG, Fine DM. The impact of hepatitis C coinfection on kidney disease related to human immunodeficiency virus (HIV): a biopsy study. Medicine. 90: 289-95. PMID 21857365 DOI: 10.1097/Md.0B013E31822F5915 |
0.56 |
|
| 2011 |
Mullen BA, Cook K, Moore RD, Rand C, Galai N, McCaul ME, Glass S, Oursler KK, Lucas GM. Study design and participant characteristics of a randomized controlled trial of directly administered antiretroviral therapy in opioid treatment programs. Bmc Infectious Diseases. 11: 45. PMID 21324133 DOI: 10.1186/1471-2334-11-45 |
0.482 |
|
| 2011 |
Altice FL, Bruce RD, Lucas GM, Lum PJ, Korthuis PT, Flanigan TP, Cunningham CO, Sullivan LE, Vergara-Rodriguez P, Fiellin DA, Cajina A, Botsko M, Nandi V, Gourevitch MN, Finkelstein R, et al. HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study. Journal of Acquired Immune Deficiency Syndromes (1999). 56: S22-32. PMID 21317590 DOI: 10.1097/Qai.0B013E318209751E |
0.595 |
|
| 2011 |
Chaudhry AA, Botsko M, Weiss L, Egan JE, Mitty J, Estrada B, Lucas GM, Woodson T, Flanigan TP, Fiellin DA. Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/naloxone and HIV care. Journal of Acquired Immune Deficiency Syndromes (1999). 56: S14-21. PMID 21317589 DOI: 10.1097/Qai.0B013E318209D3B9 |
0.563 |
|
| 2011 |
Lucas GM. Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals. Life Sciences. 88: 948-52. PMID 20888839 DOI: 10.1016/J.Lfs.2010.09.025 |
0.585 |
|
| 2011 |
Izzedine H, Acharya V, Wirden M, Cluzel P, Sene D, Lucas GM, Baumelou A, Atta MG. Role of HIV-1 DNA levels as clinical marker of HIV-1-associated nephropathies. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 26: 580-3. PMID 20624771 DOI: 10.1093/Ndt/Gfq414 |
0.593 |
|
| 2010 |
Yanik EL, Lucas GM, Vlahov D, Kirk GD, Mehta SH. HIV and proteinuria in an injection drug user population. Clinical Journal of the American Society of Nephrology : Cjasn. 5: 1836-43. PMID 20705967 DOI: 10.2215/Cjn.01030210 |
0.554 |
|
| 2010 |
Lucas GM, Clarke W, Kagaayi J, Atta MG, Fine DM, Laeyendecker O, Serwadda D, Chen M, Wawer MJ, Gray RH. Decreased kidney function in a community-based cohort of HIV-Infected and HIV-negative individuals in Rakai, Uganda. Journal of Acquired Immune Deficiency Syndromes (1999). 55: 491-4. PMID 20613548 DOI: 10.1097/Qai.0B013E3181E8D5A8 |
0.617 |
|
| 2010 |
Lucas GM, Chaudhry A, Hsu J, Woodson T, Lau B, Olsen Y, Keruly JC, Fiellin DA, Finkelstein R, Barditch-Crovo P, Cook K, Moore RD. Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trial. Annals of Internal Medicine. 152: 704-11. PMID 20513828 DOI: 10.7326/0003-4819-152-11-201006010-00003 |
0.503 |
|
| 2010 |
Parkhie SM, Fine DM, Lucas GM, Atta MG. Characteristics of patients with HIV and biopsy-proven acute interstitial nephritis. Clinical Journal of the American Society of Nephrology : Cjasn. 5: 798-804. PMID 20338962 DOI: 10.2215/Cjn.08211109 |
0.577 |
|
| 2010 |
George E, Lucas GM, Nadkarni GN, Fine DM, Moore R, Atta MG. Kidney function and the risk of cardiovascular events in HIV-1-infected patients. Aids (London, England). 24: 387-94. PMID 20019575 DOI: 10.1097/Qad.0B013E3283359253 |
0.497 |
|
| 2009 |
Tabatabai S, Sperati CJ, Atta MG, Janjua K, Roxbury C, Lucas GM, Fine DM. Predictors of complication after percutaneous ultrasound-guided kidney biopsy in HIV-infected individuals: possible role of hepatitis C and HIV co-infection. Clinical Journal of the American Society of Nephrology : Cjasn. 4: 1766-73. PMID 19808221 DOI: 10.2215/Cjn.03880609 |
0.586 |
|
| 2009 |
Solomon SS, Celentano DD, Srikrishnan AK, Vasudevan CK, Anand S, Kumar MS, Solomon S, Lucas GM, Mehta SH. Mortality among injection drug users in Chennai, India (2005-2008). Aids (London, England). 23: 997-1004. PMID 19367155 DOI: 10.1097/Qad.0B013E32832A594E |
0.467 |
|
| 2009 |
Kavasery R, Galai N, Astemborski J, Lucas GM, Celentano DD, Kirk GD, Mehta SH. Nonstructured treatment interruptions among injection drug users in Baltimore, MD. Journal of Acquired Immune Deficiency Syndromes (1999). 50: 360-6. PMID 19214124 DOI: 10.1097/Qai.0B013E318198A800 |
0.527 |
|
| 2008 |
Atta MG, Deray G, Lucas GM. Antiretroviral nephrotoxicities. Seminars in Nephrology. 28: 563-75. PMID 19013327 DOI: 10.1016/j.semnephrol.2008.08.009 |
0.537 |
|
| 2008 |
Moore RD, Gebo KA, Lucas GM, Keruly JC. Rate of comorbidities not related to HIV infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use status. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 47: 1102-4. PMID 18781885 DOI: 10.1086/592115 |
0.615 |
|
| 2008 |
Burkey MD, Wilson LE, Moore RD, Lucas GM, Francis J, Gebo KA. The incidence of and risk factors for MRSA bacteraemia in an HIV-infected cohort in the HAART era. Hiv Medicine. 9: 858-62. PMID 18754806 DOI: 10.1111/J.1468-1293.2008.00629.X |
0.529 |
|
| 2008 |
Atta MG, Lucas GM, Fine DM. HIV-associated nephropathy: epidemiology, pathogenesis, diagnosis and management. Expert Review of Anti-Infective Therapy. 6: 365-71. PMID 18588500 DOI: 10.1586/14787210.6.3.365 |
0.62 |
|
| 2008 |
Fine DM, Perazella MA, Lucas GM, Atta MG. Renal disease in patients with HIV infection: epidemiology, pathogenesis and management. Drugs. 68: 963-80. PMID 18457462 DOI: 10.2165/00003495-200868070-00006 |
0.605 |
|
| 2008 |
Lucas GM, Lau B, Atta MG, Fine DM, Keruly J, Moore RD. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. The Journal of Infectious Diseases. 197: 1548-57. PMID 18422458 DOI: 10.1086/587994 |
0.487 |
|
| 2008 |
Fine DM, Perazella MA, Lucas GM, Atta MG. Kidney biopsy in HIV: beyond HIV-associated nephropathy. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 51: 504-14. PMID 18295067 DOI: 10.1053/J.Ajkd.2007.12.005 |
0.452 |
|
| 2008 |
Riedel DJ, Gebo KA, Moore RD, Lucas GM. A ten-year analysis of the incidence and risk factors for acute pancreatitis requiring hospitalization in an urban HIV clinical cohort. Aids Patient Care and Stds. 22: 113-21. PMID 18260802 DOI: 10.1089/Apc.2007.0034 |
0.436 |
|
| 2008 |
Siedner MJ, Atta MG, Lucas GM, Perazella MA, Fine DM. Poor validity of urine dipstick as a screening tool for proteinuria in HIV-positive patients. Journal of Acquired Immune Deficiency Syndromes (1999). 47: 261-3. PMID 18223364 DOI: 10.1097/Qai.0B013E31815Ac4Ad |
0.512 |
|
| 2008 |
Berliner AR, Fine DM, Lucas GM, Rahman MH, Racusen LC, Scheel PJ, Atta MG. Observations on a cohort of HIV-infected patients undergoing native renal biopsy. American Journal of Nephrology. 28: 478-86. PMID 18176076 DOI: 10.1159/000112851 |
0.588 |
|
| 2008 |
Atta MG, Fine DM, Kirk GD, Mehta SH, Moore RD, Lucas GM. Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland (Clinical Infectious Diseases (2007) 45, (1625-1632)) Clinical Infectious Diseases. 46: 488. DOI: 10.1086/527271 |
0.424 |
|
| 2007 |
Atta MG, Fine DM, Kirk GD, Mehta SH, Moore RD, Lucas GM. Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 45: 1625-32. PMID 18190325 DOI: 10.1086/523728 |
0.509 |
|
| 2007 |
Celentano DD, Lucas G. Optimizing treatment outcomes in HIV-infected patients with substance abuse issues. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 45: S318-23. PMID 18190306 DOI: 10.1086/522557 |
0.497 |
|
| 2007 |
Lucas GM, Mehta SH, Atta MG, Kirk GD, Galai N, Vlahov D, Moore RD. End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. Aids (London, England). 21: 2435-43. PMID 18025880 DOI: 10.1097/Qad.0B013E32827038Ad |
0.536 |
|
| 2007 |
Fine DM, Garg N, Haas M, Rahman MH, Lucas GM, Scheel PJ, Atta MG. Cocaine use and hypertensive renal changes in HIV-infected individuals. Clinical Journal of the American Society of Nephrology : Cjasn. 2: 1125-30. PMID 17942770 DOI: 10.2215/Cjn.02450607 |
0.417 |
|
| 2007 |
Lucas GM, Mullen BA, McCaul ME, Weidle PJ, Hader S, Moore RD. Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy. Aids Patient Care and Stds. 21: 564-74. PMID 17711381 DOI: 10.1089/Apc.2006.0192 |
0.467 |
|
| 2007 |
Spire B, Lucas GM, Carrieri MP. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST). The International Journal On Drug Policy. 18: 262-70. PMID 17689374 DOI: 10.1016/J.Drugpo.2006.12.014 |
0.511 |
|
| 2007 |
Mehta SH, Lucas G, Astemborski J, Kirk GD, Vlahov D, Galai N. Early immunologic and virologic responses to highly active antiretroviral therapy and subsequent disease progression among HIV-infected injection drug users. Aids Care. 19: 637-45. PMID 17505924 DOI: 10.1080/09540120701235644 |
0.479 |
|
| 2006 |
Mehta SH, Lucas GM, Mirel LB, Torbenson M, Higgins Y, Moore RD, Thomas DL, Sulkowski MS. Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic. Aids (London, England). 20: 2361-9. PMID 17117023 DOI: 10.1097/Qad.0B013E32801086Da |
0.485 |
|
| 2006 |
Carrieri MP, Amass L, Lucas GM, Vlahov D, Wodak A, Woody GE. Buprenorphine use: the international experience. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 43: S197-215. PMID 17109307 DOI: 10.1086/508184 |
0.553 |
|
| 2006 |
Sullivan LE, Bruce RD, Haltiwanger D, Lucas GM, Eldred L, Finkelstein R, Fiellin DA. Initial strategies for integrating buprenorphine into HIV care settings in the United States. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 43: S191-6. PMID 17109306 DOI: 10.1086/508183 |
0.567 |
|
| 2006 |
Gebo KA, Burkey MD, Lucas GM, Moore RD, Wilson LE. Incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort. Journal of Acquired Immune Deficiency Syndromes (1999). 43: 426-32. PMID 17099314 DOI: 10.1097/01.Qai.0000243120.67529.78 |
0.556 |
|
| 2006 |
Lucas GM, Mullen BA, Weidle PJ, Hader S, McCaul ME, Moore RD. Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 42: 1628-35. PMID 16652321 DOI: 10.1086/503905 |
0.488 |
|
| 2006 |
Barry PM, Zetola N, Keruly JC, Moore RD, Gebo KA, Lucas GM. Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990-2003. Aids (London, England). 20: 437-44. PMID 16439878 DOI: 10.1097/01.Aids.0000206507.54901.84 |
0.501 |
|
| 2006 |
Lucas GM, Griswold M, Gebo KA, Keruly J, Chaisson RE, Moore RD. Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy. American Journal of Epidemiology. 163: 412-20. PMID 16394200 DOI: 10.1093/Aje/Kwj059 |
0.531 |
|
| 2005 |
Moore RD, Keruly JC, Gebo KA, Lucas GM. An improvement in virologic response to highly active antiretroviral therapy in clinical practice from 1996 through 2002. Journal of Acquired Immune Deficiency Syndromes (1999). 39: 195-8. PMID 15905736 |
0.46 |
|
| 2005 |
Vlahov D, Galai N, Safaeian M, Galea S, Kirk GD, Lucas GM, Sterling TR. Effectiveness of highly active antiretroviral therapy among injection drug users with late-stage human immunodeficiency virus infection. American Journal of Epidemiology. 161: 999-1012. PMID 15901620 DOI: 10.1093/Aje/Kwi133 |
0.431 |
|
| 2005 |
Lucas GM. Antiretroviral adherence, drug resistance, viral fitness and HIV disease progression: a tangled web is woven. The Journal of Antimicrobial Chemotherapy. 55: 413-6. PMID 15722389 DOI: 10.1093/Jac/Dki042 |
0.547 |
|
| 2004 |
Lucas GM, Wu AW, Cheever LW. Adherence to antiretroviral therapy: an update of current concepts. Current Hiv/Aids Reports. 1: 172-80. PMID 16091239 DOI: 10.1007/S11904-004-0027-6 |
0.487 |
|
| 2004 |
Lucas GM. Buprenorphine in primary HIV care clinics: a big pill to swallow. The Hopkins Hiv Report : a Bimonthly Newsletter For Healthcare Providers / Johns Hopkins University Aids Service. 16: 5-7. PMID 15386835 |
0.435 |
|
| 2004 |
Lucas GM, Gallant JE, Moore RD. Relationship between drug resistance and HIV-1 disease progression or death in patients undergoing resistance testing. Aids (London, England). 18: 1539-48. PMID 15238772 DOI: 10.1097/01.Aids.0000131339.68666.1A |
0.45 |
|
| 2004 |
Lucas GM, Weidle PJ, Hader S, Moore RD. Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 38: S409-13. PMID 15156431 DOI: 10.1086/421405 |
0.55 |
|
| 2004 |
Lucas GM, Eustace JA, Sozio S, Mentari EK, Appiah KA, Moore RD. Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. Aids (London, England). 18: 541-6. PMID 15090808 DOI: 10.1097/00002030-200402200-00022 |
0.517 |
|
| 2003 |
Lucas GM, Chaisson RE, Moore RD. Survival in an urban HIV-1 clinic in the era of highly active antiretroviral therapy: a 5-year cohort study. Journal of Acquired Immune Deficiency Syndromes (1999). 33: 321-8. PMID 12843742 DOI: 10.1097/00126334-200307010-00005 |
0.524 |
|
| 2002 |
Lucas GM, Flexner CW, Moore RD. Directly administered antiretroviral therapy in the treatment of HIV infection: benefit or burden? Aids Patient Care and Stds. 16: 527-35. PMID 12513901 DOI: 10.1089/108729102761041083 |
0.497 |
|
| 2002 |
Erbelding EJ, Lucas GM, Gandhi RT. HIV notes from the 40th annual meeting of the Infectious Diseases Society of America. The Hopkins Hiv Report : a Bimonthly Newsletter For Healthcare Providers / Johns Hopkins University Aids Service. 14: 6-7. PMID 12491991 |
0.422 |
|
| 2002 |
Lucas GM, Gebo KA, Chaisson RE, Moore RD. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. Aids (London, England). 16: 767-74. PMID 11964533 DOI: 10.1097/00002030-200203290-00012 |
0.523 |
|
| 2002 |
Lucas GM. HIV notes from the 39th Annual Meeting of the IDSA. The Hopkins Hiv Report : a Bimonthly Newsletter For Healthcare Providers / Johns Hopkins University Aids Service. 14: 8-10. PMID 11851124 |
0.473 |
|
| 2001 |
Lucas GM. HIV-associated lymphomas: the last opportunists? The Hopkins Hiv Report : a Bimonthly Newsletter For Healthcare Providers / Johns Hopkins University Aids Service. 13. PMID 12184253 |
0.499 |
|
| 2001 |
Lucas GM. Directly observed therapy for the treatment of HIV: promises and pitfalls The Hopkins Hiv Report : a Bimonthly Newsletter For Healthcare Providers / Johns Hopkins University Aids Service. 13. PMID 11682851 |
0.469 |
|
| 2001 |
Lucas GM, Chaisson RE, Moore RD. Comparison of initial combination antiretroviral therapy with a single protease inhibitor, ritonavir and saquinavir, or efavirenz Aids. 15: 1679-1686. PMID 11546943 DOI: 10.1097/00002030-200109070-00011 |
0.505 |
|
| 2001 |
Lucas GM, Cheever LW, Chaisson RE, Moore RD. Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection Journal of Acquired Immune Deficiency Syndromes. 27: 251-259. PMID 11464144 DOI: 10.1097/00126334-200107010-00006 |
0.529 |
|
| 2000 |
Lucas GM. Report from the 38th IDSA: preserving the immune response to HIV, HAART, and long-term toxicities The Hopkins Hiv Report : a Bimonthly Newsletter For Healthcare Providers / Johns Hopkins University Aids Service. 12. PMID 12184244 |
0.345 |
|
| 1999 |
Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions Annals of Internal Medicine. 131: 81-87. PMID 10419445 DOI: 10.7326/0003-4819-131-2-199907200-00002 |
0.545 |
|
| Show low-probability matches. |